메뉴 건너뛰기




Volumn 93, Issue 3, 2006, Pages 263-270

Medical treatment of metastatic or recurrent cancer of the cervix;Traitement médical des cancers du col utérin métastatiques ou récidivants

Author keywords

Cervical cancer; Chemotherapy; Immunotherapy; Metastatic; Recurrent; Targeted therapy

Indexed keywords

CISPLATIN; TOPOTECAN; ANTINEOPLASTIC AGENT;

EID: 33645417257     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (4)

References (55)
  • 2
    • 0142062150 scopus 로고    scopus 로고
    • Human papillomavirus and cervical cancer-burden and assessment of causality
    • Bosch F, de Sanjose S. Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 2003: 3-13.
    • (2003) J Natl Cancer Inst Monogr , pp. 3-13
    • Bosch, F.1    De Sanjose, S.2
  • 3
    • 0034243425 scopus 로고    scopus 로고
    • FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers
    • FIGO Committee on Gynecologic Oncology
    • Benedet JL, Bender H, Jones H, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000; 70: 209-62.
    • (2000) Int J Gynaecol Obstet , vol.70 , pp. 209-262
    • Benedet, J.L.1    Bender, H.2    Jones, H.3    Ngan, H.Y.4    Pecorelli, S.5
  • 4
    • 0038470985 scopus 로고    scopus 로고
    • Standards, Options and Recommendations for the management of invasive cervical cancer patients (non metastastic)
    • Resbeut M, Fondrinier E, Fervers B, Haie-Meder C, Bataillard A, Lhomme C, et al. Standards, Options and Recommendations for the management of invasive cervical cancer patients (non metastastic). Bull Cancer 2003; 90: 333-46.
    • (2003) Bull Cancer , vol.90 , pp. 333-346
    • Resbeut, M.1    Fondrinier, E.2    Fervers, B.3    Haie-Meder, C.4    Bataillard, A.5    Lhomme, C.6
  • 5
    • 0029880366 scopus 로고    scopus 로고
    • Cancer of the uterine cervix
    • Cannistra SA, Niloff JM. Cancer of the uterine cervix. N Engl J Med 1996; 334: 1030-8.
    • (1996) N Engl J Med , vol.334 , pp. 1030-1038
    • Cannistra, S.A.1    Niloff, J.M.2
  • 7
    • 0028044566 scopus 로고
    • Chemotherapy for cervix cancer
    • Omura GA. Chemotherapy for cervix cancer. Semin Oncol 1994; 21: 54-62.
    • (1994) Semin Oncol , vol.21 , pp. 54-62
    • Omura, G.A.1
  • 8
    • 1542439958 scopus 로고    scopus 로고
    • The role of chemotherapy in the management of carcinoma of the cervix
    • Thigpen T. The role of chemotherapy in the management of carcinoma of the cervix. Cancer J 2003; 9: 425-32.
    • (2003) Cancer J , vol.9 , pp. 425-432
    • Thigpen, T.1
  • 9
    • 0021793908 scopus 로고
    • Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: A Gynecologic Oncology Group study
    • Bonomi P, Blessing JA, Stehman FB, DiSaia PJ, Walton L, Major FJ. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1985; 3: 1079-85.
    • (1985) J Clin Oncol , vol.3 , pp. 1079-1085
    • Bonomi, P.1    Blessing, J.A.2    Stehman, F.B.3    Disaia, P.J.4    Walton, L.5    Major, F.J.6
  • 10
    • 0019408691 scopus 로고
    • Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group
    • Thigpen T, Shingleton H, Homesley H, Lagasse L, Blessing J. Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Cancer 1981; 48: 899-903.
    • (1981) Cancer , vol.48 , pp. 899-903
    • Thigpen, T.1    Shingleton, H.2    Homesley, H.3    Lagasse, L.4    Blessing, J.5
  • 11
    • 0024561232 scopus 로고
    • A randomised comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A Gynecologic Oncology Group study
    • Thigpen JT, Blessing JA, DiSaia PJ, Fowler Jr. WC, Hatch KD. A randomised comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1989; 32: 198-202.
    • (1989) Gynecol Oncol , vol.32 , pp. 198-202
    • Thigpen, J.T.1    Blessing, J.A.2    Disaia, P.J.3    Fowler Jr., W.C.4    Hatch, K.D.5
  • 12
    • 0023611941 scopus 로고
    • Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: A Southwest Oncology Group Study
    • Alberts DS, Kronmal R, Baker LH, Stock-Novack DL, Surwit EA, Boutselis JG, et al. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study. J Clin Oncol 1987; 5: 1791-5.
    • (1987) J Clin Oncol , vol.5 , pp. 1791-1795
    • Alberts, D.S.1    Kronmal, R.2    Baker, L.H.3    Stock-Novack, D.L.4    Surwit, E.A.5    Boutselis, J.G.6
  • 13
    • 0031023552 scopus 로고    scopus 로고
    • Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: A Gynecologic Oncology Group study
    • Omura GA, Blessing JA, Vaccarello L, Berman ML, Clarke-Pearson DL, Mutch DG, et al. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1997; 15: 165-71.
    • (1997) J Clin Oncol , vol.15 , pp. 165-171
    • Omura, G.A.1    Blessing, J.A.2    Vaccarello, L.3    Berman, M.L.4    Clarke-Pearson, D.L.5    Mutch, D.G.6
  • 14
    • 0036534291 scopus 로고    scopus 로고
    • Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: A gynecologic oncology group study
    • Bloss JD, Blessing JA, Behrens BC, Mannel RS, Rader JS, Sood AK, et al. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2002; 20: 1832-7.
    • (2002) J Clin Oncol , vol.20 , pp. 1832-1837
    • Bloss, J.D.1    Blessing, J.A.2    Behrens, B.C.3    Mannel, R.S.4    Rader, J.S.5    Sood, A.K.6
  • 15
    • 4143135504 scopus 로고    scopus 로고
    • Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: A gynecologic oncology group study
    • Moore DH, Blessing JA, McQuellon RP, Thaler HT, Cella D, Benda J, et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2004; 22: 3113-9.
    • (2004) J Clin Oncol , vol.22 , pp. 3113-3119
    • Moore, D.H.1    Blessing, J.A.2    McQuellon, R.P.3    Thaler, H.T.4    Cella, D.5    Benda, J.6
  • 16
    • 0034908766 scopus 로고    scopus 로고
    • Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: An EORTC Gynecological Cancer Cooperative Group study
    • Vermorken JB, Zanetta G, De Oliveira CF, van der Burg ME, Lacave AJ, Teodorovic I, et al. Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study. Ann Oncol 2001; 12: 967-74.
    • (2001) Ann Oncol , vol.12 , pp. 967-974
    • Vermorken, J.B.1    Zanetta, G.2    De Oliveira, C.F.3    Van Der Burg, M.E.4    Lacave, A.J.5    Teodorovic, I.6
  • 17
    • 23044495279 scopus 로고    scopus 로고
    • Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: A Gynecologic Oncology Group Study
    • Long 3rd HJ, Bundy BN, Grendys jr. EC, Benda JA, McMeekin DS, Sorosky J, et al. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2005; 23: 4626-33.
    • (2005) J Clin Oncol , vol.23 , pp. 4626-4633
    • Long III, H.J.1    Bundy, B.N.2    Grendys Jr., E.C.3    Benda, J.A.4    McMeekin, D.S.5    Sorosky, J.6
  • 18
    • 0022610203 scopus 로고
    • Treatment of metastatic and recurrent cervix cancer with chemotherapy: A randomised trial comparing hydroxyurea with cisdiamminedichloro-platinum plus methotrexate
    • Bezwoda W, Nissenbaum M, Derman D. Treatment of metastatic and recurrent cervix cancer with chemotherapy: a randomised trial comparing hydroxyurea with cisdiamminedichloro-platinum plus methotrexate. Med Pediatr Oncol 1986; 14: 17-9.
    • (1986) Med Pediatr Oncol , vol.14 , pp. 17-19
    • Bezwoda, W.1    Nissenbaum, M.2    Derman, D.3
  • 19
    • 0028242566 scopus 로고
    • Chemotherapy of recurrent/advanced cervical cancer: Results of the Yale University PBM-PFU protocol
    • Chambers SK, Lamb L, Kohorn EI, Schwartz PE, Chambers JT. Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol. Gynecol Oncol 1994; 53: 161-9.
    • (1994) Gynecol Oncol , vol.53 , pp. 161-169
    • Chambers, S.K.1    Lamb, L.2    Kohorn, E.I.3    Schwartz, P.E.4    Chambers, J.T.5
  • 20
    • 0022482045 scopus 로고
    • A phase II study of carboplacin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study)
    • Arsentau J, Blessing JA, Stehman FB, McGehee R. A phase II study of carboplacin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study). Invest New Drugs 1986; 4: 187-91.
    • (1986) Invest New Drugs , vol.4 , pp. 187-191
    • Arsentau, J.1    Blessing, J.A.2    Stehman, F.B.3    McGehee, R.4
  • 21
    • 0024350119 scopus 로고
    • A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: A Gynecologic Oncology Group study
    • McGuire 3rd WP, Arseneau J, Blessing JA, DiSaia PJ, Hatch KD, Given FT, et al. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol 1989; 7: 1462-8.
    • (1989) J Clin Oncol , vol.7 , pp. 1462-1468
    • McGuire III, W.P.1    Arseneau, J.2    Blessing, J.A.3    Disaia, P.J.4    Hatch, K.D.5    Given, F.T.6
  • 22
    • 0347623112 scopus 로고    scopus 로고
    • New drugs in the treatment of recurrent or metastatic cervical cancer
    • Savarese A, Cognetti F. New drugs in the treatment of recurrent or metastatic cervical cancer. Crit Rev Oncol Hematol 2003; 48: 323-7.
    • (2003) Crit Rev Oncol Hematol , vol.48 , pp. 323-327
    • Savarese, A.1    Cognetti, F.2
  • 23
    • 0029865737 scopus 로고    scopus 로고
    • Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study
    • McGuire WP, Blessing JA, Moore D, Lentz SS, Photopulos G. Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. J Clin Oncol 1996; 14: 792-5.
    • (1996) J Clin Oncol , vol.14 , pp. 792-795
    • McGuire, W.P.1    Blessing, J.A.2    Moore, D.3    Lentz, S.S.4    Photopulos, G.5
  • 25
    • 8944249284 scopus 로고    scopus 로고
    • Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix
    • Kudelka AP, Verschraegen CF, Levy T, Edwards CL, Fishman A, Freedman RS, et al. Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix. Anticancer Drugs 1996; 7: 398-401.
    • (1996) Anticancer Drugs , vol.7 , pp. 398-401
    • Kudelka, A.P.1    Verschraegen, C.F.2    Levy, T.3    Edwards, C.L.4    Fishman, A.5    Freedman, R.S.6
  • 26
    • 0031037244 scopus 로고    scopus 로고
    • Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix
    • Verschraegen CF, Levy T, Kudelka AP, Llerena E, Ende K, Freedman RS, et al. Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix. J Clin Oncol 1997; 15: 625-31.
    • (1997) J Clin Oncol , vol.15 , pp. 625-631
    • Verschraegen, C.F.1    Levy, T.2    Kudelka, A.P.3    Llerena, E.4    Ende, K.5    Freedman, R.S.6
  • 27
    • 0032887487 scopus 로고    scopus 로고
    • Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix
    • Lhomme C, Fumoleau P, Fargeot P, Krakowski Y, Dieras V, Chauvergne J, et al. Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix. J Clin Oncol 1999; 17: 3136-42.
    • (1999) J Clin Oncol , vol.17 , pp. 3136-3142
    • Lhomme, C.1    Fumoleau, P.2    Fargeot, P.3    Krakowski, Y.4    Dieras, V.5    Chauvergne, J.6
  • 29
    • 0000315609 scopus 로고    scopus 로고
    • A phase II study of gemcitabine in advanced cervix carcinoma: Final data
    • Goedhals L, Bezwoda W. A phase II study of gemcitabine in advanced cervix carcinoma: final data. Proc Am Soc Clin Oncol 1996: 754A.
    • (1996) Proc Am Soc Clin Oncol
    • Goedhals, L.1    Bezwoda, W.2
  • 30
    • 0033959650 scopus 로고    scopus 로고
    • Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: A phase II study of the gynecologic oncology group
    • Schilder RJ, Blessing JA, Morgan M, Mangan CE, Rader JS. Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a phase II study of the gynecologic oncology group. Gynecol Oncol 2000; 76: 204-7.
    • (2000) Gynecol Oncol , vol.76 , pp. 204-207
    • Schilder, R.J.1    Blessing, J.A.2    Morgan, M.3    Mangan, C.E.4    Rader, J.S.5
  • 31
    • 0031909627 scopus 로고    scopus 로고
    • Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix
    • Morris M, Brader KR, Levenback C, Burke TW, Atkinson EN, Scott WR, et al. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix. J Clin Oncol 1998; 16: 1094-8.
    • (1998) J Clin Oncol , vol.16 , pp. 1094-1098
    • Morris, M.1    Brader, K.R.2    Levenback, C.3    Burke, T.W.4    Atkinson, E.N.5    Scott, W.R.6
  • 32
    • 0033970201 scopus 로고    scopus 로고
    • Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: An EORTC Gynaecological Cancer Cooperative Group Study
    • Lhomme C, Vermorken JB, Mickiewicz E, Chevalier B, Alvarez A, Mendiola C, et al. Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study. Eur J Cancer 2000; 36: 194-9.
    • (2000) Eur J Cancer , vol.36 , pp. 194-199
    • Lhomme, C.1    Vermorken, J.B.2    Mickiewicz, E.3    Chevalier, B.4    Alvarez, A.5    Mendiola, C.6
  • 33
    • 0027391873 scopus 로고
    • Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: Study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC)
    • Chauvergne J, Fumoleau P, Cappelaere P, Metz R, Armand JP, Chevallier B, et al. Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 1993; 29A: 350-4.
    • (1993) Eur J Cancer , vol.29 A , pp. 350-354
    • Chauvergne, J.1    Fumoleau, P.2    Cappelaere, P.3    Metz, R.4    Armand, J.P.5    Chevallier, B.6
  • 35
    • 33645969479 scopus 로고    scopus 로고
    • Phase II study of capecitabine in cisplatin-pretreated metastatic or recurrent squamous cell carcinoma of the cervix
    • abstract 507 P
    • Stamatovic L, Vasovic S, Karaferic A, Tomasevic Z, Jelic S. Phase II study of capecitabine in cisplatin-pretreated metastatic or recurrent squamous cell carcinoma of the cervix. Ann Oncol 2004; (15: abstract 507 P).
    • (2004) Ann Oncol , Issue.15
    • Stamatovic, L.1    Vasovic, S.2    Karaferic, A.3    Tomasevic, Z.4    Jelic, S.5
  • 36
    • 0032744560 scopus 로고    scopus 로고
    • Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer
    • Zanetta G, Fei F, Parma G, Balestrino M, Lissoni A, Gabriele A, et al. Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer. Ann Oncol 1999; 10: 1171-4.
    • (1999) Ann Oncol , vol.10 , pp. 1171-1174
    • Zanetta, G.1    Fei, F.2    Parma, G.3    Balestrino, M.4    Lissoni, A.5    Gabriele, A.6
  • 37
    • 0036080739 scopus 로고    scopus 로고
    • Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: A phase II study of the Hellenic Cooperative Oncology Group
    • Dimopoulos MA, Papadimitriou CA, Sarris K, Aravantinos G, Kalofonos C, Gika D, et al. Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group. Gynecol Oncol 2002; 85: 476-82.
    • (2002) Gynecol Oncol , vol.85 , pp. 476-482
    • Dimopoulos, M.A.1    Papadimitriou, C.A.2    Sarris, K.3    Aravantinos, G.4    Kalofonos, C.5    Gika, D.6
  • 39
    • 0007094156 scopus 로고    scopus 로고
    • Paclitaxel and Carboplatin as First Line Treatment for Advanced Carcinoma of the Cervix
    • abstract 825
    • Mickiewicz E. Paclitaxel and Carboplatin as First Line Treatment for Advanced Carcinoma of the Cervix. Proc Am Soc Clin Oncol 2001; (abstract 825).
    • (2001) Proc Am Soc Clin Oncol
    • Mickiewicz, E.1
  • 41
    • 0037498599 scopus 로고    scopus 로고
    • Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer
    • Chitapanarux I, Tonusin A, Sukthomya V, Charuchinda C, Pukanhapan N, Lorvidhaya V. Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer. Gynecol Oncol 2003; 89: 402-7.
    • (2003) Gynecol Oncol , vol.89 , pp. 402-407
    • Chitapanarux, I.1    Tonusin, A.2    Sukthomya, V.3    Charuchinda, C.4    Pukanhapan, N.5    Lorvidhaya, V.6
  • 42
    • 17144453674 scopus 로고    scopus 로고
    • Gemcitabine in cervical cancer
    • Mutch DG, Bloss JD. Gemcitabine in cervical cancer. Gynecol Oncol 2003; 90: (S8-15).
    • (2003) Gynecol Oncol , vol.90
    • Mutch, D.G.1    Bloss, J.D.2
  • 44
    • 1142269367 scopus 로고    scopus 로고
    • A phase II trial to evaluate efficacy and safety of gefitinib (ZD1839) in patients with loco-regionally advanced or metastatic squamous-cell carcinoma of the cervix
    • abstr 1833
    • Viens P, Lhommé C, Extra J, Gladieff L, Kalla, SFabbro M. A phase II trial to evaluate efficacy and safety of gefitinib (ZD1839) in patients with loco-regionally advanced or metastatic squamous-cell carcinoma of the cervix. Proc Am Soc Clin Oncol 2003; 22: 456; (abstr 1833).
    • (2003) Proc Am Soc Clin Oncol , vol.22 , pp. 456
    • Viens, P.1    Lhommé, C.2    Extra, J.3    Gladieff, L.4    Kalla, S.5    Fabbro, M.6
  • 46
    • 0037198442 scopus 로고    scopus 로고
    • Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer
    • Santin AD, Bellone S, Gokden M, Cannon MJ, Parham GP. Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer. N Engl J Med 2002; 346: 1752-3.
    • (2002) N Engl J Med , vol.346 , pp. 1752-1753
    • Santin, A.D.1    Bellone, S.2    Gokden, M.3    Cannon, M.J.4    Parham, G.P.5
  • 47
    • 0032831008 scopus 로고    scopus 로고
    • Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: A gynecologic oncology group study
    • Rose PG, Blessing JA, Gershenson DM, McGehee R. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 1999; 17: 2676-80.
    • (1999) J Clin Oncol , vol.17 , pp. 2676-2680
    • Rose, P.G.1    Blessing, J.A.2    Gershenson, D.M.3    McGehee, R.4
  • 48
    • 0025340840 scopus 로고
    • A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: A Southwest Oncology Group trial
    • Weiss GR, Green S, Hannigan EV, Boutselis JG, Surwit EA, Wallace DL, et al. A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial. Gynecol Oncol 1990; 37: 354-8.
    • (1990) Gynecol Oncol , vol.37 , pp. 354-358
    • Weiss, G.R.1    Green, S.2    Hannigan, E.V.3    Boutselis, J.G.4    Surwit, E.A.5    Wallace, D.L.6
  • 49
    • 0026799423 scopus 로고
    • Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: A second look
    • Ramm K, Vergote IB, Kaern J, Trope CG. Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look. Gynecol Oncol 1992; 46: 203-7.
    • (1992) Gynecol Oncol , vol.46 , pp. 203-207
    • Ramm, K.1    Vergote, I.B.2    Kaern, J.3    Trope, C.G.4
  • 50
    • 0036356151 scopus 로고    scopus 로고
    • Vinorelbine and cisplatin for the treatment of recurrent and/or metastatic carcinoma of the uterine cervix
    • Gebbia V, Caruso M, Testa A, Mauceri G, Borsellino N, Chiarenza M, et al. Vinorelbine and cisplatin for the treatment of recurrent and/or metastatic carcinoma of the uterine cervix. Oncology 2002; 63: 31-7.
    • (2002) Oncology , vol.63 , pp. 31-37
    • Gebbia, V.1    Caruso, M.2    Testa, A.3    Mauceri, G.4    Borsellino, N.5    Chiarenza, M.6
  • 51
    • 0033957908 scopus 로고    scopus 로고
    • A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix
    • Burnett AF, Roman LD, Garcia AA, Muderspach LI, Brader KR, Morrow CP. A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 2000; 76: 63-6.
    • (2000) Gynecol Oncol , vol.76 , pp. 63-66
    • Burnett, A.F.1    Roman, L.D.2    Garcia, A.A.3    Muderspach, L.I.4    Brader, K.R.5    Morrow, C.P.6
  • 52
    • 0027341641 scopus 로고
    • Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide
    • Chauvergne J, Heron JF, Mayer F, Charrot-Chinet P, Toulouse C. Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide. Bull Cancer 1993; 80: 70-9.
    • (1993) Bull Cancer , vol.80 , pp. 70-79
    • Chauvergne, J.1    Heron, J.F.2    Mayer, F.3    Charrot-Chinet, P.4    Toulouse, C.5
  • 53
    • 0035498749 scopus 로고    scopus 로고
    • Phase II srudy of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix
    • Verschraegen CF, Kavanagh JJ, Loyer E, Bodurka-Bevers D, Kudelka AP, Hu W, et al. Phase II srudy of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix. Cancer 2001; 92: 2327-33.
    • (2001) Cancer , vol.92 , pp. 2327-2333
    • Verschraegen, C.F.1    Kavanagh, J.J.2    Loyer, E.3    Bodurka-Bevers, D.4    Kudelka, A.P.5    Hu, W.6
  • 54
    • 0036227178 scopus 로고    scopus 로고
    • Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix
    • Fiorica J, Holloway R, Ndubisi B, Orr J, Grendys E, Boothby R, et al. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix. Gynecol Oncol 2002; 85: 89-94.
    • (2002) Gynecol Oncol , vol.85 , pp. 89-94
    • Fiorica, J.1    Holloway, R.2    Ndubisi, B.3    Orr, J.4    Grendys, E.5    Boothby, R.6
  • 55
    • 0842288949 scopus 로고    scopus 로고
    • Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma
    • Tiersten AD, Selleck MJ, Hershman DL, Smith D, Resnik EE, Troxel AB, et al. Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma. Gynecol Oncol 2004; 92: 635-8.
    • (2004) Gynecol Oncol , vol.92 , pp. 635-638
    • Tiersten, A.D.1    Selleck, M.J.2    Hershman, D.L.3    Smith, D.4    Resnik, E.E.5    Troxel, A.B.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.